About Attends
Attends is a company based in Greenville (United States) founded in 1979 was acquired by Domtar in January 2012. Attends offers products and services including Attends Premier Underwear, Attends Discreet Women's Maximum Pads, Attends Briefs, and Attends Wipes. Attends operates in a competitive market with competitors including Axonics, Amber Therapeutics, NeuSpera Medical, UroMems and MyoPowers Medical Technologies, among others.
- Headquarter Greenville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Attends Healthcare Products, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Attends
Attends offers a comprehensive portfolio of products and services, including Attends Premier Underwear, Attends Discreet Women's Maximum Pads, Attends Briefs, and Attends Wipes.
Absorbent underwear for heavy urinary incontinence protection.
Pads for light to moderate bladder leak management.
Disposable briefs offering extended wear for severe leaks.
Flushable wipes for cleaning and skin care needs.
People of Attends
Unlock access to complete
Unlock access to complete
Funding Insights of Attends
Investors in Attends
Attends has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Domtar, KPS Capital Partners and Wellsfargocapitalfinance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A private equity firm focused on manufacturing and industrial investments.
|
Locked | Locked | Locked | |
|
Rutland Partners is engaged in private equity investments in the UK mid-market.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Attends
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Attends
Investment portfolio details for Attends
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Attends
Detailed financials for Attends
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Attends Comparisons
Peer comparison for Attends
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Attends
Attends operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Amber Therapeutics, NeuSpera Medical, UroMems and MyoPowers Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| Locked | Locked | Locked |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| Locked | Locked | Locked |
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
|
|
| Locked | Locked | Locked |
Developer of active implantable devices for urological incontinence
|
|
| Locked | Locked | Locked |
An implantable device for the treatment of urinary incontinence stress
|
|
| Locked | Locked | Locked |
Urological devices for post-prostatectomy incontinence are developed by Levee Medical.
|
Detailed competitors of Attends
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Attends
Complete news archive for Attends
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Attends
Attends was founded in 1979 and raised its 1st funding round 28 years after it was founded.
Attends is headquartered in Greenville, United States.
Attends Healthcare Products(known as PaperPak Products till 2007) manufactures and markets adult incontinence products for customers in North America. The company offers protective underwear, briefs, pads, under-pads, wipes, washcloths and tissues for women, men and young people. Its products are used for light to severe urinary and fecal incontinence for ambulatory as well as bedridden users. The company offers its products and services through dealers, retailers(both online offline), distributors, and healthcare facilities. . Attends Healthcare was sold by KPS capital partners to Domtar Corporation in 2011 for 315M.
Attends's top competitors include Axonics, NeuSpera Medical and Amber Therapeutics.
Attends offers Attends Premier Underwear, Attends Discreet Women's Maximum Pads, Attends Briefs, and Attends Wipes.
Attends has 4 investors. Key investors include Domtar, KPS Capital Partners, Wellsfargocapitalfinance, and Rutland Partners.